Vaccines, Clinical Advancement, and Associated Immunology
A section of Vaccines (ISSN 2076-393X).
Section Information
Aims
The aim of the Section “Vaccines, Clinical Advancement, and Associated Immunology” is to highlight advances in vaccines and the associated immunology, vaccine clinical advancement, and vaccine-induced immunological changes, including immune-based adverse events induced by vaccines. This Section will provide a forum for novel insights into immunological mechanisms, translational applications, and the development of new vaccines.
Scope
We welcome articles focusing on the immunology of vaccines for infectious diseases, the design and development of new vaccines, and the clinical aspects of vaccinations, including adverse events and clinical entities that may occur following prophylactic and therapeutic vaccination. We also welcome submissions addressing preclinical and clinical studies related to vaccination in patients with immune-mediated disorders. The Section encourages translational research bridging experimental findings with human applications, and will consider original research articles, brief reports, reviews, and others relevant article types.
Keywords
- clinical immunology
- immune-mediated diseases
- vaccine adverse events
- vaccine immunopathology
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Human Immune Responses to Infection and Vaccination (Deadline: 31 December 2025)
- Immune-Mediated Diseases Following Vaccination (Deadline: 31 December 2025)
- Immune Responses in Patients with Inflammatory Bowel Disease After Vaccination (Deadline: 31 January 2026)
- Respiratory Viruses and Antiviral Immunity (Deadline: 31 January 2026)
- Analysis of Vaccine-Induced Adaptive Immune Responses (Deadline: 31 January 2026)
- Herpes Simplex Virus Infection, Immunity, and Vaccine Development (Deadline: 31 March 2026)
- Vaccines and Immunotherapy for Inflammatory Disease (Deadline: 31 March 2026)
- Research on Immune Response and Vaccines: 2nd Edition (Deadline: 30 April 2026)
- Immune Responses in Patients with Chronic Disease After Vaccination (Deadline: 30 April 2026)
- Genetically Engineered Mouse Models in Vaccine Development (Deadline: 30 April 2026)
- Mucosal Immunity and Vaccine (Deadline: 30 June 2026)
- Antibodies in Autoimmune, Chronic, and Infectious Diseases: Pathogenic Mechanisms, Biomarkers, and Vaccine Development (Deadline: 30 June 2026)
- Antiviral T and B Cell Immunity (Deadline: 15 July 2026)
- Immunogenicity, Safety, and Coverage of Vaccines in Patients with Autoimmune Diseases (Deadline: 31 July 2026)
- Immune Correlates of Protection in Vaccines, 2nd Edition (Deadline: 15 August 2026)
- Neurobiological Impacts of Infection, Protective Effects, and Clinical Implications of Vaccines (Deadline: 30 September 2026)
- Novel Immunotherapeutic Strategies Targeting Autoimmune and Inflammatory Diseases (Deadline: 31 October 2026)
